Capital Raising & Corporate Finance
CFO Corner: Tiziano Ceccarani, Mundys
Mundys' CFO Tiziano Ceccarani sat down with Global Finance to discuss the challenges of the pandemic and going private.
Author: Tiziana Barghini
Join the global community of corporate and public-sector finance industry leaders reading Global Finance monthly in print.
Click Here
Capital Raising & Corporate Finance
Musk Names New Twitter CEO
Elon Musk hires Linda Yaccarino, an experienced advertising executive, to run Twitter in his place.
Capital Raising & Corporate Finance
New Cash Challenge
High interest rates are forcing CFOs to leave no stone unturned in the search for working capital.
Capital Raising & Corporate Finance
CFO Corner: Alicia Mondolo, Tenaris
Tenaris CFO Alicia Mondolospoke with Global Financeabout the changing role of the CFO.
Capital Raising & Corporate Finance
The ‘Go Anywhere’ Strategy: Q&A With Cook & Bynum Co-founder Richard Cook
Richard Cook, co-founder of Cook & Bynum, a value and long-term investor with $300 million AUM, talks about searching for undervalued assets and the “on-the-ground research” approach.
Economics, Policy & Regulation
Dreaming Of Safe Banks In A Nightmare Scenario
Could the SVB and Signature Bank runs have been prevented?
Economics, Policy & Regulation
World Bank: Quick Leadership Turnaround
World Bank President David Malpass—a Trump administration appointee—will soon be replaced by theBiden administration's pick,former Mastercard CEO Ajay Banga.
Capital Raising & Corporate Finance
Activist Investors Swarm Salesforce Amid Layoffs
Salesforce joins Microsoft and other tech companies in reducing headcount.
News
After Much Turnover, Peru Gets First Female President
Without a majority in Congress,Dina Boluarte's ability to governis limited.
News
Indonesia: International Aid Helps In Carbon Reduction
Indonesia’s power sector emissions will peak by 2030 and reach net zero by 2050, about a decade ahead of schedule.
Executive Interviews
Investing For Life: Q&A With Sofinnova Chairman Antoine Papiernik
Paris-based Sofinnova Partners, a life science venture capital firm, has been an early investor in companies such Genentech and Biogen, and now has over $2.5 billion invested in sciences, primarily in healthcare and sustainability. Antoine Papiernik, Sofinnova chairman and managing partner, speaks with Global Finance about the state of life sciences today and in future.
News
License To Pollute
The newest carbon-credit initiative out of COP27 doesn’t seem to answer the old critiques.